↓ Skip to main content

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Overview of attention for article published in Thrombosis Journal, September 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#18 of 419)
  • High Attention Score compared to outputs of the same age (92nd percentile)

Mentioned by

blogs
1 blog
policy
2 policy sources
twitter
7 X users
patent
1 patent

Citations

dimensions_citation
482 Dimensions

Readers on

mendeley
303 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
Published in
Thrombosis Journal, September 2013
DOI 10.1186/1477-9560-11-21
Pubmed ID
Authors

Martin H Prins, Anthonie WA Lensing, Rupert Bauersachs, Bonno van Bellen, Henri Bounameaux, Timothy A Brighton, Alexander T Cohen, Bruce L Davidson, Hervé Decousus, Gary E Raskob, Scott D Berkowitz, Philip S Wells

Abstract

Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of anticoagulant effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 303 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 2 <1%
United States 2 <1%
France 2 <1%
Italy 2 <1%
Brazil 1 <1%
Chile 1 <1%
Egypt 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
Other 1 <1%
Unknown 289 95%

Demographic breakdown

Readers by professional status Count As %
Other 54 18%
Researcher 44 15%
Student > Master 33 11%
Student > Postgraduate 29 10%
Student > Bachelor 27 9%
Other 76 25%
Unknown 40 13%
Readers by discipline Count As %
Medicine and Dentistry 182 60%
Pharmacology, Toxicology and Pharmaceutical Science 15 5%
Agricultural and Biological Sciences 12 4%
Biochemistry, Genetics and Molecular Biology 5 2%
Economics, Econometrics and Finance 5 2%
Other 21 7%
Unknown 63 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2023.
All research outputs
#1,790,168
of 25,837,817 outputs
Outputs from Thrombosis Journal
#18
of 419 outputs
Outputs of similar age
#15,600
of 215,645 outputs
Outputs of similar age from Thrombosis Journal
#1
of 4 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 419 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,645 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them